Acute and chronic cardioprotection by the enkephalin analogue, eribis peptide 94, is mediated via activation of nitric oxide synthase and adenosine triphosphate-regulated potassium channels

Pharmacology

Volumn 90, Issue 1-2, 2012, Pages 110-116

  Gross, Garrett J ^a   Hsu, Anna ^a   Nithipatikom, Kasem ^a   Pfeiffer, Adam W ^a   Bobrova, Irina ^b   Bissessar, Erik ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Eribis Pharmaceuticals AB   (Sweden)

Author keywords

KATP channels; Myocardial infarction; Nitric oxide; Opioid peptides

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CLAMIKALANT; DELTA OPIATE RECEPTOR; ENKEPHALIN DERIVATIVE; EREBIS PEPTIDE 94; INDUCIBLE NITRIC OXIDE SYNTHASE; MU OPIATE RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; EXPERIMENTAL MODEL; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REPERFUSION INJURY;

ANIMALS; BENZAMIDES; CARDIOTONIC AGENTS; DECANOIC ACIDS; ENKEPHALINS; HYDROXY ACIDS; KATP CHANNELS; MALE; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

EID: 84863873307     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000340058     Document Type: Article

References (20)

1. Schultz JE, Rose E, Yao Z, Gross GJ: Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 1995;268:H2157-H2161.
2. Schultz JE, Hsu AK, Gross GJ: Morphine mimics the cardioprotective effect of isch-emic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996;78:1100-1104.
3. Zatta AJ, Kin H, Yoshishige D, Jiang R, Wang N, Reeves JG, Mykytenko J, Guyton RA, Zhao ZQ, Caffrey JL, Vinten-Johansen J: Evidence that cardioprotection by postcondi-tioning involves preservation of myocardial opioid content and selective opioid receptor activation. Am J Physiol Heart Circ Physiol 2008;294:H1444-H1451.
4. Barron BA: Cardiac opioids. Proc Soc Exp Biol Med 2000;224:1-7.
5. Karlsson LO, Grip L, Bissessar E, Bobrova I, Gustafsson T, Kavianipour M, Odenstedt J, Wikstrom G, Gonon AT: Opioid receptor agonist Eribis peptide 94 reduces infarct size in different porcine models for myocardial ischaemia and reperfusion. Eur J Pharmacol 2011;651:146-151.
6. Burkard N, Williams T, Czolbe M, Blomer N, Panther F, Link M, Fraccarollo D, Wid-der JD, Hu K, Han H, Hofmann U, Frantz S, Nordbeck P, Bulla J, Schuh K, Ritter O: Conditional overexpression of neuronal nitric oxide synthase is cardioprotective in isch-emia/reperfusion. Circulation 2010;122: 1588-1603.
7. Jones SP, Greer JJ, Kakkar AK, Ware PD, Turnage RH, Hicks M, van Haperen R, de Crom R, Kawashima S, Yokoyama M, Lefer DJ: Endothelial nitric oxide synthase overex-pression attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 2004; 286:H276-H282.
8. Shinmura K, Xuan YT, Tang XL, Kodani E, Han H, Zhu Y, Bolli R: Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning. Circ Res 2002;90:602-608.
9. Frassdorf J, Weber NC, Obal D, Toma O, Mullenheim J, Kojda G, Preckel B, Schlack W: Morphine induces late cardioprotec-tion in rat hearts in vivo: the involvement of opioid receptors and nuclear transcription factor kappaB. Anesth Analg 2005;101: 934-941.
10. Liang BT, Gross GJ: Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res 1999;84:1396-1400.
11. Gross ER, Gross GJ: Ischemic preconditioning and myocardial infarction: an update and perspective. Drug Discov Today Dis Mech 2007;4:165-174.
12. Gross ER, Gross GJ: Pharmacologic therapeutics for cardiac reperfusion injury. Expert Opin Emerg Drugs 2007;12:367-388.
13. Fryer RM, Wang Y, Hsu AK, Gross GJ: Essential activation of PKC-delta in opioid-ini-tiated cardioprotection. Am J Physiol Heart Circ Physiol 2001;280:H1346-H1353.
14. Jiang X, Shi E, Nakajima Y, Sato S: Inducible nitric oxide synthase mediates delayed car-dioprotection induced by morphine in vivo: evidence from pharmacologic inhibition and gene-knockout mice. Anesthesiology 2004; 101:82-88.
15. Fryer RM, Hsu AK, Eells JT, Nagase H, Gross GJ: Opioid-induced second window of cardioprotection: potential role of mito-chondrial KATP channels. Circ Res 1999;84: 846-851.
16. Patel HH, Hsu AK, Gross GJ: Cox-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat. Life Sci 2004;75:129-140.
17. Gross GJ, Hsu A, Nithipatikom K, Bobrova I, Bissessar E: Eribis peptide 94 reduces infarct size in rat hearts via activation of centrally located μ-opioid receptors. J Cardiovasc Pharmacol 2012;59:194-197.
18. Caimmi P P, Molinari C, Uberti F, Micalizzi E, Valente G, Mary DA, Vacca G, Grossini E: Intracoronary levosimendan prevents myocardial ischemic damages and activates survival signaling through ATP-sensitive potassium channel and nitric oxide. Eur J Cardiothorac Surg 2011;39:e59-e67.
19. Peart JN, Hoe LE, Gross GJ, Headrick JP: Sustained ligand-activated preconditioning via δ-opioid receptors. J Pharmacol Exp Ther 2011;336:274-281.
20. Bencsik P, Kupai K, Giricz Z, Görbe A, Pipis J, Murlasits Z, Kocsis GF, Varga-Orvos Z, Puskás LG, Csonka C, Csont T, Ferdinandy P: Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signaling in myocardi-al late preconditioning in rats. Am J Physiol Heart Circ Physiol. 2010;299:H512-H518.